Table 2.
Unadjusted and adjusted odds ratios of all biomarkers for malignant brain edema
| Unadjusted | Adjusted a | |||
|---|---|---|---|---|
| OR (95 % CI) | P value | OR (95 % CI) | P value | |
| NLRP3 | 1.72 (1.06, 2.79) | 0.03 | 1.47 (0.88, 2.46) | 0.14 |
| HIF 1α | 0.72 (0.37, 1.37) | 0.31 | 0.61 (0.31, 1.20) | 0.15 |
| CTSB | 1.12 (0.26, 4.95) | 0.88 | 0.80 (0.17, 3.79) | 0.78 |
| CASP1 | 1.14 (0.86, 1.51) | 0.36 | 1.15 (0.86, 1.55) | 0.34 |
| MMP9 | 1.00 (0.97, 1.04) | 0.95 | 1.00 (0.96, 1.04) | 0.87 |
CASP-1, Caspase-1; CI: confidence interval; CTSB, cathepsin B; HIF-1α, hypoxia inducible factor-1α; MMP9, Matrix Metalloproteinase-9; NLRP3, nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3; OR, odds ratio. Data of serum level of biomarkers were Ln-transformed for analysis. a adjusted variables included age and National Institutes of Health Stroke Scale score